TA B L E 1 Mean ± SD of the analytes, HI and hemoglobin concentrations for each group, %bias from NH for analytes, ±acceptable limits from CLIA'88, and these results with higher bias than TAE limits, and statistically significant differences compared with NH are marked in bold The total allowed error for HBDH was assumed to be 30% according to experience.
a ±10% bias was set as the accepted TAE for the analytes because they are not included in the CLIA'88 regulations.
b
To compare with the TAE defined as ERROR in CLIA'88, the hemolysis effects on Ca, K, Na, and CK-MB are expressed as bias directly. c Significant differences exist among the five groups when compared with each other (P < 0.05).
TA B L E 1 (Continued)
tubes. 2, 7 Traditionally, hemolysis is detected by visual detection, but this method is time-intensive, arbitrary, and rather subjective, which consequently impact clinical decisions. 8 Moreover, it is difficult to visually detect subtle differences in color between hemolysis and icteric samples. The continuous-flow automatic system leaves little chance for visual detection, and it has been reported that intravenous catheters and vacuum blood-drawing technology might result in a higher risk of hemolysis; 9 therefore, the increasing use of these technologies makes it more challenging to quickly identify hemolysis specimens.
Hemolysis index (HI) generated by analyzers is an effective tool to counteract the hemolysis challenge, as it can standardize the process of identifying hemolytic specimens and estimate the hemolysis interferences quantitatively. [10] [11] [12] [13] [14] [15] [16] [17] Even though it was reported that the hemolysis index (HI) was accurate and highly reproducible among different platforms and laboratories, 16 to the corresponding reagent protocols. The assay reagents were obtained from the same vendor as the analyzer system (Siemens Healthcare Diagnostics Inc, Deerfield, IL, USA). The hemoglobin (Hb) level was measured on an XE-5000 hematology analyzer (Sysmex Corporation, Kobe, Japan). Laboratory Improvement Amendments of 1988 (CLIA'88) established TAE for assessing methods and laboratory performance for specific regulated analytes. 18 We chose ±10% as maximum allowable bias for TBA, LDL-C, APO-A1, APO-B, GGT, HBDH, P, and Lp(a), as there are no given acceptable limits in CLIA'88 for them. 19 The 2-tailed t test was used to compare analyte concentrations between hemolysis groups and the baseline group (no hemolysis).
| Statistical analysis
These results revealed a higher bias than TAE limits, and statistical differences from baseline concentrations were considered to be clinically significantly interfered by hemolysis. In order to identify HI thresholds for interference analysts, we used the "curve estimation" in SPSS including linear, logarithmic, inverse, quadratic, and cubic models to select the model with the highest R2 and the lowest P values. We then used the GraphPad Prism 7 to produce graph and formula of regression curves chosen from the curve estimation, through which we could precisely locate the x (HI) and y (bias) coordinates on the curves. The HI corresponding to the bias limits (TAE or ±10%) was considered as the HI threshold. A P value of <0.05 was considered statistically significant. Table 1 .
| RE SULTS
At first, the Hb concentrations in the five groups were measured to evaluate the relationship between HI and Hb. The HI values among the five groups were significantly different when compared to each other (P < 0.05); there was a strong association between HI and Hb concentrations ( Table 1 , r = 0.982, P < 0.05, Supplement Figure S1 ).
In baseline samples, the Hb concentrations were <0.5 g/mL; both TBIL (10.93 ± 2.7 umol/L) and TG (1.02 ± 0.51 mmol/L) concentrations were less than the corresponding lower reference limits.
We then compared analyte concentrations between hemolysis groups and the baseline group. The concentrations of AST, TBA, ALB, LDH, CK, CKMB, HBDH, GLU, UA, K, and Na in hemolysis groups were significantly different from that of the NH ( TAE, total allowed error recommended by CLIA'88 regulations; NA, not available. The total allowed error for hydroxybutyrate dehydrogenase was assumed to be 30% according to experience. a ±10% bias was set as the accepted TAE for the analytes because they are not included in the CLIA'88 regulations. Hemoglobin was estimated from equation HI = 120*Hb-68, supplement Figure S1 .
In our study, though the hemolysis interference on biochemistry analytes was dependent on the analyzer system, the interference on CK, AST, LDH, and K was consistent with former studies using the Cobas 6000 c501 analyzer 22 or Roche analyzers. 15 This confirmed that a common mechanism underlies the observed hemolysis interference. The mechanisms behind the hemolysis interferences include the additive interferences of released intracellular substances (eg, LDH, AST, K, and HBDH) and the chemical interferences when the released substances interacted with the measured analyte (eg, CK and CKMB); 23 it was reported that intracellular adenylate kinase might interfere with the CK assay. 12 In addition, our results showed that positive hemolysis interferences on CK-MB activity started to increase at lower HI values compared with CK activity, which was in accordance with Oğuzhan Özcan's study. 24 The reason may be that the errors from the interfering agents released by hemolysis were amplified by multiplying a constant; this constant parameter is commonly used to calculate the CKMB activity in the assay. We also observed that UA, GLU, Na, and TBA decreased due to hemolysis, which may result from the dilution effects caused by the leakage of intracellular components into the surrounding fluid. However, GLU was less affected in MH than SH, which was also reported in another study. 12 This phenomenon might be due to the interaction between the spectral interference of the released hemoglobin and the dilution effects owing to the leakage of intracellular components.
We found that the HI thresholds for AST (10.16), HBDH (7.94), and K (4.07) were even lower than the slight hemolysis flag judgment Some limitations in our study are worth noting. Firstly, hemolysis interference was investigated only at one single concentration level, which was generally normal. On the other hand, the CLSI recommends testing at least two medical decision concentrations. 25 Secondly, hemolysis produced by aspirating blood through syringe needles does not account for the different hemolysis causes in clinical practice. 1, 26 Finally, the protocol used in the present interference study did not allow us to distinguish the effects of hemoglobin from those of released erythrocytic, leukocytic, and thrombocytic constituents. Future research should focus on a high-volume and multiple level investigation for the HI thresholds.
In conclusion, this is the first study to our knowledge that investigated HI thresholds using the Advia 2400 analyzer, which extended these HI studies. [10] [11] [12] [13] [14] [15] [16] [17] [20] [21] [22] 24 Our results provide HI thresholds for eight analytes (CKMB, CK, K, AST, HBDH, TBA, Na, and UA). These analyses would be inappropriate for reporting when their HI values are higher than the corresponding HI thresholds. The implementation of the assay-specific HI thresholds can provide an accurate means to identify the extent to which hemolysis interferes with analytes. This would lead to better clinical interpretations and may improve the laboratory test quality by reducing errors associated with hemolysis.
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